Citation: C. Deng et al., FAS-MEDIATED APOPTOSIS IS ONE OF THE MECHANISMS OF HIGH-DOSE ACETYLCHOLINE-RECEPTOR T-CELL EPITOPE TOLERANCE IN EXPERIMENTAL MYASTHENIA-GRAVIS, The FASEB journal, 12(4), 1998, pp. 1809-1809
Authors:
DEDHIA V
GOLUSZKO E
WU B
DENG CS
CHRISTADOSS P
Citation: V. Dedhia et al., THE EFFECT OF B-CELL DEFICIENCY ON THE IMMUNE-RESPONSE TO ACETYLCHOLINE-RECEPTOR AND THE DEVELOPMENT OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS, Clinical immunology and immunopathology (Print), 87(3), 1998, pp. 266-275
Authors:
KAUL R
WU B
GOLUSZKO E
DENG CS
DEDHIA V
NABOZNY GH
DAVID CS
RIMM IJ
SHENOY M
HAQQI TM
CHRISTADOSS P
Citation: R. Kaul et al., EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS IN B10.BV8S2 TRANSGENIC MICE - PREFERENTIAL USAGE OF TCRAV1 GENE BY LYMPHOCYTES RESPONDING TO ACETYLCHOLINE-RECEPTOR, The Journal of immunology, 158(12), 1997, pp. 6006-6012
Authors:
DENG C
GOLUSZKO E
WU B
BARON S
DEDHIA V
CHRISTADOSS P
Citation: C. Deng et al., INTERFERON-ALPHA THERAPY FOR ESTABLISHED CLINICAL EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS INDUCES REMISSION, The FASEB journal, 10(6), 1996, pp. 152-152
Citation: V. Dedhia et al., ROLE OF CD8-CELLS IN THE PATHOGENESIS OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS (EAMG)( T), The FASEB journal, 10(6), 1996, pp. 1760-1760